Table 1.
Baseline characteristics of the study population with a baseline DXA or MRI scan
| Baseline characteristics | Patients with a DXA scan (n = 93) | Patients with an MRI scan (n = 99) |
|---|---|---|
| Age (years) | 55.6 (10.8) | 55.6 (10.1) |
| Male (%) | 39 (41.9) | 46 (46.5) |
| Race (%) | ||
| White | 74 (79.6) | 81 (81.8) |
| Asian | 17 (18.3) | 14 (14.1) |
| Black | 2 (2.2) | 4 (4.0) |
| Time since T2D diagnosis (years) | ||
| ≤1 | 12 (12.9) | 9 (9.1) |
| >1–5 | 35 (37.6) | 45 (45.5) |
| >5–10 | 27 (29.0) | 23 (23.2) |
| >10 | 19 (20.4) | 22 (22.2) |
| HbA1c (%) | 8.19 (1.02) | 8.20 (0.99) |
| Fasting glucose (mg/dL) | 159.3 (45.9) | 161.7 (47.2) |
| Triglycerides (mg/dL) | 183.0 (116.1)a | 216.3 (259.6)d |
| HDL cholesterol (mg/dL) | 46.4 (10.6)a | 45.2 (10.6)d |
| LDL cholesterol (mg/dL) | 96.0 (31.3)a | 97.4 (32.0)e |
| Total cholesterol (mg/dL) | 177.8 (38.9)a | 181.5 (43.7)d |
| AST (U/L) | 26.7 (19.4)a | 26.6 (17.8)d |
| ALT (U/L) | 34.1 (25.6)a | 34.9 (25.4)d |
| Body weight (kg) | 84.1 (15.2) | 87.4 (16.3) |
| Body mass index (kg/m2) | 31.9 (4.9) | 32.4 (4.9) |
| Waist circumference (cm) | 103.9 (12.1) | 106.1 (12.3) |
| Est total body fat (%) | 37.4 (9.9) | 37.1 (9.6) |
| Index of central obesity | 0.64 (0.08) | 0.65 (0.08) |
| Visceral adiposity index | 3.3 (3.1)a | 4.4 (8.5)d |
| Total fat mass (%) | 38.4 (8.4) | 38.9 (8.0)b |
| Fat-free mass (kg) | 50.8 (10.7) | 50.7 (11.2)b |
| Visceral fat mass (cm2) | 164.1 (81.3)b | 174.0 (80.7) |
| Abdominal subcutaneous fat mass (cm2) | 338.4 (107.6)c | 342.2 (111.4) |
Data are mean (standard deviation) or n (%).
DXA dual x-ray absorptiometry, MRI magnetic resonance imaging, T2D Type 2 diabetes, HbA1c glycosylated hemoglobin, HDL high-density lipoprotein, LDL low-density lipoprotein, AST Aspartate transaminase, ALT Alanine transaminase
Subjects with data available: a n = 92; b n = 74; c n = 73; d n = 98; e n = 97